T1	Participants 314 421	One hundred fifty-seven patients were screened for cognitive deficits following HSCT for malignant diseases
T2	Participants 473 713	atients showing evidence of impairment were randomly assigned to one of two training groups: individualized PC-supported training or neuropsychological group therapy. The control group consisted of patients who received no specific training
